MCCARTHY SEAN A. (President and CEO) sold 3.6% of their position (37.66K shares) of CYTOMX THERAPEUTICS, INC. on the open market
Open‑market sale worth $22.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/20/2025ACC: 0001610717-25-000086
DirectorOfficer· President and CEO
Since Jul 2018
-37.66K
Net shares
Net seller
$22.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
37.66K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−37.66K
Price / share
$0.60
Trade value
$22.56K
% of position
3.6%
3/18/2025
1.03M→995.20K
Total
Net shares
−37.66K
Net value
-$22.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/18/2025 | S · Sale | −37.66K | $0.60 | $22.56K | 3.6% | 1.03M | 995.20K |
| Total | −37.66K | -$22.56K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned93.16K
Total
93.16K indirect93.16K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 93.16K | Indirect |
| Total | 93.16K | 93.16K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported